Literature DB >> 25618792

Blood lipids and colorectal polyps: testing an etiologic hypothesis using phenotypic measurements and Mendelian randomization.

Michael N Passarelli1, Polly A Newcomb, Karen W Makar, Andrea N Burnett-Hartman, John D Potter, Melissa P Upton, Lee-Ching Zhu, Michael E Rosenfeld, Stephen M Schwartz, Carolyn M Rutter.   

Abstract

PURPOSE: Studies linking cholesterol levels to the development of colorectal neoplasia are inconsistent, and Mendelian randomization has been suggested as a way to help avoid problems with confounding and reverse causation.
METHODS: We genotyped individuals who received a colonoscopy at Group Health (1998-2007) for 96 of 102 single-nucleotide polymorphisms identified by the Global Lipids Genetics Consortium. Participants included 139 advanced adenoma cases, 518 non-advanced adenoma cases, 380 non-adenomatous polyp cases, and 754 polyp-free controls. All had at least one available pre-colonoscopy lipid measurement from electronic records maintained by Group Health.
RESULTS: Advanced adenoma cases were more likely than controls to have higher pre-colonoscopy zenith low-density lipoprotein (LDL), triglycerides (TG), and total cholesterol (TC) (odds ratio, OR per 20 mg/dL LDL increase: 1.16, 95 % confidence interval, CI 1.03-1.30; per 40 mg/dL TG increase: 1.09, 1.03-1.16; and per 20 mg/dL TC increase: 1.09, 1.02-1.18). For these traits, genotype-polyp ORs using weighted allele scores were not statistically significant (OR per increase in score scaled to a 20 mg/dL LDL increase: 1.17, 0.78-1.75; a 40 mg/dL TG increase: 1.12, 0.91-1.38; a 20 mg/dL TC increase: 0.99, 0.71-1.38).
CONCLUSIONS: Cholesterol levels may be associated with advanced adenomas, but larger studies are warranted to determine whether this association can be attributed to genetics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25618792      PMCID: PMC4334709          DOI: 10.1007/s10552-015-0526-3

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  29 in total

1.  Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.

Authors:  Brandon L Pierce; Habibul Ahsan; Tyler J Vanderweele
Journal:  Int J Epidemiol       Date:  2010-09-02       Impact factor: 7.196

2.  Calculating statistical power in Mendelian randomization studies.

Authors:  Marie-Jo A Brion; Konstantin Shakhbazov; Peter M Visscher
Journal:  Int J Epidemiol       Date:  2013-10       Impact factor: 7.196

3.  Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.

Authors:  Bing Cai; Dylan S Small; Thomas R Ten Have
Journal:  Stat Med       Date:  2011-04-15       Impact factor: 2.373

4.  Estimating the heritability of colorectal cancer.

Authors:  Shuo Jiao; Ulrike Peters; Sonja Berndt; Hermann Brenner; Katja Butterbach; Bette J Caan; Christopher S Carlson; Andrew T Chan; Jenny Chang-Claude; Stephen Chanock; Keith R Curtis; David Duggan; Jian Gong; Tabitha A Harrison; Richard B Hayes; Brian E Henderson; Michael Hoffmeister; Laurence N Kolonel; Loic Le Marchand; John D Potter; Anja Rudolph; Robert E Schoen; Daniela Seminara; Martha L Slattery; Emily White; Li Hsu
Journal:  Hum Mol Genet       Date:  2014-02-21       Impact factor: 6.150

5.  Variation in the association between colorectal cancer susceptibility loci and colorectal polyps by polyp type.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; Carolyn M Hutter; Ulrike Peters; Michael N Passarelli; Malaika R Schwartz; Melissa P Upton; Lee-Ching Zhu; John D Potter; Karen W Makar
Journal:  Am J Epidemiol       Date:  2014-05-29       Impact factor: 4.897

Review 6.  New insights into the aetiology of colorectal cancer from genome-wide association studies.

Authors:  Albert Tenesa; Malcolm G Dunlop
Journal:  Nat Rev Genet       Date:  2009-06       Impact factor: 53.242

7.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

8.  Biological, clinical and population relevance of 95 loci for blood lipids.

Authors:  Tanya M Teslovich; Kiran Musunuru; Albert V Smith; Andrew C Edmondson; Ioannis M Stylianou; Masahiro Koseki; James P Pirruccello; Samuli Ripatti; Daniel I Chasman; Cristen J Willer; Christopher T Johansen; Sigrid W Fouchier; Aaron Isaacs; Gina M Peloso; Maja Barbalic; Sally L Ricketts; Joshua C Bis; Yurii S Aulchenko; Gudmar Thorleifsson; Mary F Feitosa; John Chambers; Marju Orho-Melander; Olle Melander; Toby Johnson; Xiaohui Li; Xiuqing Guo; Mingyao Li; Yoon Shin Cho; Min Jin Go; Young Jin Kim; Jong-Young Lee; Taesung Park; Kyunga Kim; Xueling Sim; Rick Twee-Hee Ong; Damien C Croteau-Chonka; Leslie A Lange; Joshua D Smith; Kijoung Song; Jing Hua Zhao; Xin Yuan; Jian'an Luan; Claudia Lamina; Andreas Ziegler; Weihua Zhang; Robert Y L Zee; Alan F Wright; Jacqueline C M Witteman; James F Wilson; Gonneke Willemsen; H-Erich Wichmann; John B Whitfield; Dawn M Waterworth; Nicholas J Wareham; Gérard Waeber; Peter Vollenweider; Benjamin F Voight; Veronique Vitart; Andre G Uitterlinden; Manuela Uda; Jaakko Tuomilehto; John R Thompson; Toshiko Tanaka; Ida Surakka; Heather M Stringham; Tim D Spector; Nicole Soranzo; Johannes H Smit; Juha Sinisalo; Kaisa Silander; Eric J G Sijbrands; Angelo Scuteri; James Scott; David Schlessinger; Serena Sanna; Veikko Salomaa; Juha Saharinen; Chiara Sabatti; Aimo Ruokonen; Igor Rudan; Lynda M Rose; Robert Roberts; Mark Rieder; Bruce M Psaty; Peter P Pramstaller; Irene Pichler; Markus Perola; Brenda W J H Penninx; Nancy L Pedersen; Cristian Pattaro; Alex N Parker; Guillaume Pare; Ben A Oostra; Christopher J O'Donnell; Markku S Nieminen; Deborah A Nickerson; Grant W Montgomery; Thomas Meitinger; Ruth McPherson; Mark I McCarthy; Wendy McArdle; David Masson; Nicholas G Martin; Fabio Marroni; Massimo Mangino; Patrik K E Magnusson; Gavin Lucas; Robert Luben; Ruth J F Loos; Marja-Liisa Lokki; Guillaume Lettre; Claudia Langenberg; Lenore J Launer; Edward G Lakatta; Reijo Laaksonen; Kirsten O Kyvik; Florian Kronenberg; Inke R König; Kay-Tee Khaw; Jaakko Kaprio; Lee M Kaplan; Asa Johansson; Marjo-Riitta Jarvelin; A Cecile J W Janssens; Erik Ingelsson; Wilmar Igl; G Kees Hovingh; Jouke-Jan Hottenga; Albert Hofman; Andrew A Hicks; Christian Hengstenberg; Iris M Heid; Caroline Hayward; Aki S Havulinna; Nicholas D Hastie; Tamara B Harris; Talin Haritunians; Alistair S Hall; Ulf Gyllensten; Candace Guiducci; Leif C Groop; Elena Gonzalez; Christian Gieger; Nelson B Freimer; Luigi Ferrucci; Jeanette Erdmann; Paul Elliott; Kenechi G Ejebe; Angela Döring; Anna F Dominiczak; Serkalem Demissie; Panagiotis Deloukas; Eco J C de Geus; Ulf de Faire; Gabriel Crawford; Francis S Collins; Yii-der I Chen; Mark J Caulfield; Harry Campbell; Noel P Burtt; Lori L Bonnycastle; Dorret I Boomsma; S Matthijs Boekholdt; Richard N Bergman; Inês Barroso; Stefania Bandinelli; Christie M Ballantyne; Themistocles L Assimes; Thomas Quertermous; David Altshuler; Mark Seielstad; Tien Y Wong; E-Shyong Tai; Alan B Feranil; Christopher W Kuzawa; Linda S Adair; Herman A Taylor; Ingrid B Borecki; Stacey B Gabriel; James G Wilson; Hilma Holm; Unnur Thorsteinsdottir; Vilmundur Gudnason; Ronald M Krauss; Karen L Mohlke; Jose M Ordovas; Patricia B Munroe; Jaspal S Kooner; Alan R Tall; Robert A Hegele; John J P Kastelein; Eric E Schadt; Jerome I Rotter; Eric Boerwinkle; David P Strachan; Vincent Mooser; Kari Stefansson; Muredach P Reilly; Nilesh J Samani; Heribert Schunkert; L Adrienne Cupples; Manjinder S Sandhu; Paul M Ridker; Daniel J Rader; Cornelia M van Duijn; Leena Peltonen; Gonçalo R Abecasis; Michael Boehnke; Sekar Kathiresan
Journal:  Nature       Date:  2010-08-05       Impact factor: 49.962

9.  Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.

Authors:  Jiping Wang; Luis G Carvajal-Carmona; Jen-Hwa Chu; Ann G Zauber; Michikai Kubo; Koichi Matsuda; Malcolm Dunlop; Richard S Houlston; Oliver Sieber; Lara Lipton; Peter Gibbs; Nicholas G Martin; Grant W Montgomery; Joanne Young; Paul N Baird; Mark J Ratain; Yusuke Nakamura; Scott T Weiss; Ian Tomlinson; Monica M Bertagnolli
Journal:  Clin Cancer Res       Date:  2013-10-01       Impact factor: 12.531

10.  Use of allele scores as instrumental variables for Mendelian randomization.

Authors:  Stephen Burgess; Simon G Thompson
Journal:  Int J Epidemiol       Date:  2013-08       Impact factor: 7.196

View more
  6 in total

Review 1.  Blood Lipid Concentrations and Colorectal Adenomas: A Systematic Review and Meta-Analysis of Colonoscopy Studies in Asia, 2000-2014.

Authors:  Michael N Passarelli; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2016-03-24       Impact factor: 4.897

2.  Performance of the Use of Genetic Information to Assess the Risk of Colorectal Cancer in the Basque Population.

Authors:  Koldo Garcia-Etxebarria; Ane Etxart; Maialen Barrero; Beatriz Nafria; Nerea Miren Segues Merino; Irati Romero-Garmendia; Andre Franke; Mauro D'Amato; Luis Bujanda
Journal:  Cancers (Basel)       Date:  2022-08-29       Impact factor: 6.575

3.  MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer.

Authors:  Kyungjin Lee; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

4.  Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause.

Authors:  Gemma Ibáñez-Sanz; Anna Díez-Villanueva; Marina Riera-Ponsati; Tania Fernández-Villa; Pablo Fernández Navarro; Mariona Bustamante; Javier Llorca; Pilar Amiano; Nieves Ascunce; Guillermo Fernández-Tardón; Inmaculada Salcedo Bellido; Dolores Salas; Rocío Capelo Álvarez; Marta Crous-Bou; Luis Ortega-Valín; Beatriz Pérez-Gómez; Gemma Castaño-Vinyals; Camilo Palazuelos; Jone M Altzibar; Eva Ardanaz; Adonina Tardón; José Juan Jiménez Moleón; Valle Olmos Juste; Nuria Aragonés; Marina Pollán; Manolis Kogevinas; Victor Moreno
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

5.  Interplay between Genome, Metabolome and Microbiome in Colorectal Cancer.

Authors:  Koldo Garcia-Etxebarria; Marc Clos-Garcia; Oiana Telleria; Beatriz Nafría; Cristina Alonso; Marta Iruarrizaga-Lejarreta; Andre Franke; Anais Crespo; Agueda Iglesias; Joaquín Cubiella; Luis Bujanda; Juan Manuel Falcón-Pérez
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

6.  Systematic review of Mendelian randomization studies on risk of cancer.

Authors:  Georgios Markozannes; Afroditi Kanellopoulou; Olympia Dimopoulou; Dimitrios Kosmidis; Xiaomeng Zhang; Lijuan Wang; Evropi Theodoratou; Dipender Gill; Stephen Burgess; Konstantinos K Tsilidis
Journal:  BMC Med       Date:  2022-02-02       Impact factor: 11.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.